OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
April 02, 2010
As the industry continues to evolve, do we know where we're headed?
An established show has several new programs that reflect the industry's current challenges.
Laboratory personnel share interesting tales as well as stories of unexpected tails.
As demand for global vaccine development and production grows, all eyes are turning to Asia.
Interphex Showcase 2010.
The BIO convention, and healthcare reform, could re-energize biotech.
Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.
Growth in the market for monoclonal antibodies, recombinant proteins, and vaccines creates new opportunities for drug companies and suppliers.
April 01, 2010
Pfizer Invests In Nodality; SOCMA Approves New Members; And More.
March 25, 2010
Seventeen pharmaceutical markets are now ranked as "pharmerging," according to market-research firm IMS Health.